Home
/
Glucotrack, Inc.
/
Financials
/
Quarterly
Glucotrack, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Glucotrack, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Dec 31, 2018
$17.00B
Nov 13, 2019
Q1
2018
Mar 31, 2018
$28.2K
May 15, 2018
Q3
2017
Sep 30, 2017
$20.9K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$8.7K
Aug 14, 2017
Q1
2018
Mar 31, 2017
$96.2K
May 15, 2018
Q3
2017
Sep 30, 2016
$11.3K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$381.7K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$89.1K
May 15, 2017
Q3
2016
Sep 30, 2015
$143.2K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$67.3K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$75.8K
May 16, 2016
Q3
2015
Sep 30, 2014
$27.3K
Nov 16, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$2.3K
Nov 12, 2020
Q2
2020
Jun 30, 2020
$97
Aug 14, 2020
Q1
2020
Mar 31, 2020
$2.2K
May 19, 2020
Q3
2020
Sep 30, 2019
$4.2K
Nov 12, 2020
Q2
2020
Jun 30, 2019
$110.5K
Aug 14, 2020
Q1
2020
Mar 31, 2019
$25.6K
May 19, 2020
Q3
2019
Sep 30, 2018
$43.5K
Nov 13, 2019
Q2
2019
Jun 30, 2018
$15.3K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$28.2K
May 15, 2019
Q3
2018
Sep 30, 2017
$20.9K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$8.7K
Aug 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.17M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($4.76M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($6.83M)
May 14, 2025
Q3
2025
Sep 30, 2024
($5.09M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($4.49M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.93M)
May 14, 2025
Q3
2024
Sep 30, 2023
($2.22M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.18M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.29M)
May 15, 2024
Q3
2023
Sep 30, 2022
($928.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.13M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.09M)
May 12, 2023
Q3
2022
Sep 30, 2021
($804.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($853.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($904.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($509.0K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($574.0K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($734.0K)
May 21, 2021
Q3
2020
Sep 30, 2019
($996.8K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($898.9K)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.31M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($4.80M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.50M)
May 14, 2025
Q3
2025
Sep 30, 2024
($3.25M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($4.49M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.95M)
May 14, 2025
Q3
2024
Sep 30, 2023
($2.22M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.18M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.28M)
May 15, 2024
Q3
2023
Sep 30, 2022
($929.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.12M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.09M)
May 12, 2023
Q3
2022
Sep 30, 2021
($767.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($873.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($896.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($887.0K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($611.0K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($756.0K)
May 21, 2021
Q3
2020
Sep 30, 2019
($980.5K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($894.3K)
Aug 14, 2020